MOS
GSK icon

MGO One Seven’s GSK GSK Stock Holding History

MGO One Seven’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
20,835
+636
+3% +$33.6K 0.02% 687
2026
Q1 		$1.11M Sell
20,199
-990
-5% -$53.6K 0.02% 626
2025
Q4 		$1.04M Buy
21,189
+3,070
+17% +$143K 0.02% 632
2025
Q3 		$782K Buy
18,119
+1,607
+10% +$62.8K 0.02% 659
2025
Q2 		$634K Sell
16,512
-2,410
-13% -$92.1K 0.02% 643
2025
Q1 		$733K Buy
18,922
+5,486
+41% +$201K 0.03% 522
2024
Q4 		$454K Buy
13,436
+1,997
+17% +$71.9K 0.02% 651
2024
Q3 		$468K Sell
11,439
-1,140
-9% -$46.6K 0.02% 607
2024
Q2 		$484K Sell
12,579
-632
-5% -$26.6K 0.02% 571
2024
Q1 		$566K Sell
13,211
-2,536
-16% -$105K 0.03% 485
2023
Q4 		$584K Sell
15,747
-2,623
-14% -$94.2K 0.03% 465
2023
Q3 		$666K Buy
18,370
+10,536
+134% +$374K 0.05% 354
2023
Q2 		$279K Sell
7,834
-478
-6% -$17.1K 0.03% 622
2023
Q1 		$296K Buy
8,312
+2,285
+38% +$79.9K 0.02% 676
2022
Q4 		$212K Buy
+6,027
New +$201K 0.02% 654
2022
Q2 		– Sell
-3,807
Closed -$207K – 671
2022
Q1 		$207K Buy
3,807
+18
+0.5% +$978 0.02% 609
2021
Q4 		$209K Buy
+3,789
New +$197K 0.02% 608
2020
Q4 		– Sell
-5,186
Closed -$244K – 509
2020
Q3 		$244K Buy
5,186
+96
+2% +$4.81K 0.06% 373
2020
Q2 		$260K Sell
5,090
-57
-1% -$2.92K 0.07% 357
2020
Q1 		$243K Sell
5,147
-239
-4% -$12.7K 0.08% 319
2019
Q4 		$316K Buy
5,386
+58
+1% +$3.23K 0.08% 312
2019
Q3 		$284K Buy
5,328
+364
+7% +$18.7K 0.08% 317
2019
Q2 		$248K Buy
4,964
+584
+13% +$29.3K 0.08% 326
2019
Q1 		$228K Buy
4,380
+2,326
+113% +$116K 0.07% 342
2018
Q4 		$98K Buy
+2,054
New +$101K 0.04% 463
2018
Q1 		$105K Buy
2,142
+1,391
+185% +$64.8K 0.05% 426
2017
Q4 		$33K Buy
+751
New +$34.7K 0.02% 728

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

MGO One Seven's GSK Position: Q2 2026 in Review

MGO One Seven increased its GSK (GSK) stake by 3.1% in Q2 2026, buying an estimated $33.6K and bringing the position to 20,835 shares worth $1.09M. The position accounts for 0.02% of the portfolio, ranked #687.

MGO One Seven first reported a position in GSK in Q4 2017 and has held it in 27 quarters since. The position peaked at $1.11M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • MGO One Seven held 20,835 shares of GSK worth $1.09M as of Q2 2026.
  • MGO One Seven bought 636 GSK shares in Q2 2026, an estimated $33.6K.
  • GSK made up 0.02% of MGO One Seven's portfolio in Q2 2026, its #687 holding.
  • MGO One Seven first reported a position in GSK in Q4 2017 and has held it in 27 quarters since.
  • MGO One Seven's GSK position peaked at $1.11M in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.